These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23817209)

  • 21. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?
    Schechner V; Nobre V; Kaye KS; Leshno M; Giladi M; Rohner P; Harbarth S; Anderson DJ; Karchmer AW; Schwaber MJ; Carmeli Y
    Clin Infect Dis; 2009 Mar; 48(5):580-6. PubMed ID: 19191643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.
    Lodise TP; Patel N; Kwa A; Graves J; Furuno JP; Graffunder E; Lomaestro B; McGregor JC
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3510-5. PubMed ID: 17646415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External validation of bloodstream infection mortality risk score in a population-based cohort.
    Al-Hasan MN; Juhn YJ; Bang DW; Yang HJ; Baddour LM
    Clin Microbiol Infect; 2014 Sep; 20(9):886-91. PubMed ID: 25455590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to positivity of blood cultures in patients with bloodstream infections: A useful prognostic tool.
    Martín-Gutiérrez G; Martín-Pérez C; Gutiérrez-Pizarraya A; Lepe JA; Cisneros JM; Aznar J
    Enferm Infecc Microbiol Clin; 2017 Dec; 35(10):638-644. PubMed ID: 27916290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria.
    Thaden JT; Park LP; Maskarinec SA; Ruffin F; Fowler VG; van Duin D
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus Species: comparison of elderly and nonelderly patients.
    Marra AR; Bar K; Bearman GM; Wenzel RP; Edmond MB
    J Am Geriatr Soc; 2006 May; 54(5):804-8. PubMed ID: 16696747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.
    Almagro P; Salvadó M; Garcia-Vidal C; Rodríguez-Carballeira M; Cuchi E; Torres J; Heredia JL
    Respiration; 2012; 84(1):36-43. PubMed ID: 21996555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of bacteremia in febrile neutropenic episodes in children with cancer: microbiologic and molecular approach.
    Santolaya ME; Farfán MJ; De La Maza V; Cociña M; Santelices F; Alvarez AM; Avilés CL; Becker A; O'Ryan M; Román P; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Torres JP
    Pediatr Infect Dis J; 2011 Nov; 30(11):957-61. PubMed ID: 21768922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The microbiological and clinical analysis of bloodstream infections with identifiable sources].
    Zhang L; Liu ZY; Xu YC; Li TS; Yang QW; Wang AX
    Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):366-70. PubMed ID: 22883335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection.
    Marra AR; Edmond MB; Forbes BA; Wenzel RP; Bearman GM
    J Clin Microbiol; 2006 Apr; 44(4):1342-6. PubMed ID: 16597860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals.
    Nagao M
    Clin Microbiol Infect; 2013 Sep; 19(9):852-8. PubMed ID: 23176224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
    Zavascki AP; Barth AL; Gonçalves AL; Moro AL; Fernandes JF; Martins AF; Ramos F; Goldani LZ
    J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of bloodstream infections in burn patients: An 11-year retrospective study.
    Patel BM; Paratz JD; Mallet A; Lipman J; Rudd M; Muller MJ; Paterson DL; Roberts JA
    Burns; 2012 Aug; 38(5):685-90. PubMed ID: 22348799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bacteremia caused by Pseudomonas aeruginosa in patients with AIDS].
    Bouza Santiago E; Blázquez Garrido R; Rodríguez-Creixems M; Moreno Guillén S; Miralles Martín P; Alonso Fernández R
    Rev Clin Esp; 1996 Oct; 196(10):698-702. PubMed ID: 9005473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of DNA fingerprinting in decision making for considering closure of neonatal intensive care units because of Pseudomonas aeruginosa bloodstream infections.
    Schutze GE; Gilliam CH; Jin S; Cavenaugh CK; Hall RW; Bradsher RW; Jacobs RF
    Pediatr Infect Dis J; 2004 Feb; 23(2):110-4. PubMed ID: 14872174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P. aeruginosa bloodstream infections among hematological patients: an old or new question?
    Cattaneo C; Antoniazzi F; Casari S; Ravizzola G; Gelmi M; Pagani C; D'Adda M; Morello E; Re A; Borlenghi E; Manca N; Rossi G
    Ann Hematol; 2012 Aug; 91(8):1299-304. PubMed ID: 22349723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.
    Kang CI; Kim SH; Kim HB; Park SW; Choe YJ; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2003 Sep; 37(6):745-51. PubMed ID: 12955633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
    Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
    J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection.
    Suárez C; Peña C; Gavaldà L; Tubau F; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e73-8. PubMed ID: 20223693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.